Compare ARK Genomic Revolution ETF (ARKG) vs iShares MSCI China ETF (MCHI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares MSCI China ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.68, while iShares MSCI China ETF trades at $52.79. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares MSCI China ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | MCHI | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $66.99 |
52-Week Low | $23.09 | $50.48 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
MCHI trades at $53.13, down 0.11% on the day, with technical indicators showing a mixed but overall bullish bias. The stock exhibits neutral oscillators but bullish moving averages, while key support and resistance cluster around $53. Recent news highlights China's AI and manufacturing rebound as potential catalysts, though financial ratios are currently unavailable for fundamental assessment.
Outlook remains cautiously optimistic given technical strength and sector tailwinds, but risks include U.S.-China tech tensions and value trap concerns. Investment appeal hinges on China's economic stabilization and AI sector growth, balanced against geopolitical and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares MSCI China ETF
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →
